1. Home
  2. INGR vs GRFS Comparison

INGR vs GRFS Comparison

Compare INGR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingredion Incorporated

INGR

Ingredion Incorporated

HOLD

Current Price

$111.91

Market Cap

7.0B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.50

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGR
GRFS
Founded
1906
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.8B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INGR
GRFS
Price
$111.91
$7.50
Analyst Decision
Buy
Hold
Analyst Count
7
2
Target Price
$133.00
$10.15
AVG Volume (30 Days)
535.9K
817.0K
Earning Date
05-05-2026
07-28-2022
Dividend Yield
2.93%
1.87%
EPS Growth
15.14
N/A
EPS
11.18
N/A
Revenue
$7,219,000,000.00
N/A
Revenue This Year
$3.93
$5.33
Revenue Next Year
$2.79
$6.50
P/E Ratio
$10.01
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$102.31
$6.19
52 Week High
$141.78
$11.14

Technical Indicators

Market Signals
Indicator
INGR
GRFS
Relative Strength Index (RSI) 45.87 30.68
Support Level $109.25 N/A
Resistance Level $114.10 $9.11
Average True Range (ATR) 2.24 0.19
MACD 0.07 -0.02
Stochastic Oscillator 59.83 10.80

Price Performance

Historical Comparison
INGR
GRFS

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: